Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc

Cell Host and Microbe

Volumn 20, Issue 2, 2016, Pages 215-225

  Abed, Jawad ^a   Emgård, Johanna E M ^a   Zamir, Gideon ^b   Faroja, Mouhammad ^b   Almogy, Gideon ^b   Grenov, Amalie ^a   Sol, Asaf ^a   Naor, Ronit ^a   Pikarsky, Eli ^b,c   Atlan, Karine A ^b   Mellul, Anna ^b   Chaushu, Stella ^a   Manson, Abigail L ^d   Earl, Ashlee M ^d   Ou, Nora ^e   Brennan, Caitlin A ^e   Garrett, Wendy S ^d,e,f   Bachrach, Gilad ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAP2 PROTEIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; ADHESIN; LECTIN; PROTEIN BINDING; THOMSEN-FRIEDENREICH ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BLOODBORNE BACTERIUM; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSOBACTERIUM NUCLEATUM; GAL GALNAC GENE; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADENOCARCINOMA; ANIMAL; BACTERIUM ADHERENCE; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; COLON TUMOR; DISEASE MODEL; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ADHESINS, BACTERIAL; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BACTERIAL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FUSOBACTERIUM NUCLEATUM; HOST-PATHOGEN INTERACTIONS; HUMANS; LECTINS; MICE, INBRED BALB C; MODELS, BIOLOGICAL; PROTEIN BINDING;

EID: 84991644107     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2016.07.006     Document Type: Article

References (49)

1. Arthur, J.C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
2. Ashare, A., Stanford, C., Hancock, P., Stark, D., Lilli, K., Birrer, E., Nymon, A., Doerschug, K.C., Hunninghake, G.W., Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia. Clin. Transl. Sci. 2 (2009), 199–205.
3. Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E.H., Copeland, J.K., Kumar, S., Green, B., et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158 (2014), 288–299.
4. Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R.A., Holt, R.A., Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22 (2012), 299–306.
5. Chen, W., Liu, F., Ling, Z., Tong, X., Xiang, C., Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE, 7, 2012, e39743.
6. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
7. Coppenhagen-Glazer, S., Sol, A., Abed, J., Naor, R., Zhang, X., Han, Y.W., Bachrach, G., Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect. Immun. 83 (2015), 1104–1113.
8. Dewhirst, F.E., Chen, T., Izard, J., Paster, B.J., Tanner, A.C., Yu, W.H., Lakshmanan, A., Wade, W.G., The human oral microbiome. J. Bacteriol. 192 (2010), 5002–5017.
9. Faust, K., Sathirapongsasuti, J.F., Izard, J., Segata, N., Gevers, D., Raes, J., Huttenhower, C., Microbial co-occurrence relationships in the human microbiome. PLoS Comput. Biol., 8, 2012, e1002606.
10. Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis. 33 (2014), 1381–1390.
11. Frixen, U.H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., Birchmeier, W., E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113 (1991), 173–185.
12. Gao, S., Li, S., Ma, Z., Liang, S., Shan, T., Zhang, M., Zhu, X., Zhang, P., Liu, G., Zhou, F., et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect. Agent. Cancer, 11, 2016, 3.
13. Garrett, W.S., Cancer and the microbiota. Science 348 (2015), 80–86.
14. Giannasca, K.T., Giannasca, P.J., Neutra, M.R., Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor. Infect. Immun. 64 (1996), 135–145.
15. Grossi, S.G., Genco, R.J., Periodontal disease and diabetes mellitus: a two-way relationship. Ann. Periodontol. 3 (1998), 51–61.
16. Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 (2015), 344–355.
17. Hajishengallis, G., Liang, S., Payne, M.A., Hashim, A., Jotwani, R., Eskan, M.A., McIntosh, M.L., Alsam, A., Kirkwood, K.L., Lambris, J.D., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10 (2011), 497–506.
18. Han, Y.W., Ikegami, A., Rajanna, C., Kawsar, H.I., Zhou, Y., Li, M., Sojar, H.T., Genco, R.J., Kuramitsu, H.K., Deng, C.X., Identification and characterization of a novel adhesin unique to oral fusobacteria. J. Bacteriol. 187 (2005), 5330–5340.
19. Heng, T.S., Painter, M.W., Immunological Genome Project Consortium. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9 (2008), 1091–1094.
20. Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int. J. Cancer 137 (2015), 1258–1268.
21. Jiang, W.G., Sanders, A.J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S.K., Zollo, M., Spano, D., Dhawan, P., et al. Tissue invasion and metastasis: molecular, biological and clinical perspectives. Semin. Cancer Biol. 35:Suppl (2015), S244–S275.
22. Kaplan, C.W., Lux, R., Huynh, T., Jewett, A., Shi, W., Haake, S.K., Fusobacterium nucleatum apoptosis-inducing outer membrane protein. J. Dent. Res. 84 (2005), 700–704.
23. Kaplan, C.W., Ma, X., Paranjpe, A., Jewett, A., Lux, R., Kinder-Haake, S., Shi, W., Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect. Immun. 78 (2010), 4773–4778.
24. Katz, J., Onate, M.D., Pauley, K.M., Bhattacharyya, I., Cha, S., Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral Sci. 3 (2011), 209–215.
25. Kolenbrander, P.E., Andersen, R.N., Inhibition of coaggregation between Fusobacterium nucleatum and Porphyromonas (Bacteroides) gingivalis by lactose and related sugars. Infect. Immun. 57 (1989), 3204–3209.
26. Kolenbrander, P.E., London, J., Adhere today, here tomorrow: oral bacterial adherence. J. Bacteriol. 175 (1993), 3247–3252.
27. Kolodkin-Gal, D., Edden, Y., Hartshtark, Z., Ilan, L., Khalaileh, A., Pikarsky, A.J., Pikarsky, E., Rabkin, S.D., Panet, A., Zamir, G., Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect. Gene Ther. 16 (2009), 905–915.
28. Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., Ojesina, A.I., Jung, J., Bass, A.J., Tabernero, J., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22 (2012), 292–298.
29. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 (2013), 207–215.
30. Langlois, M.J., Bergeron, S., Bernatchez, G., Boudreau, F., Saucier, C., Perreault, N., Carrier, J.C., Rivard, N., The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. PLoS ONE, 5, 2010, e15742.
31. McCoy, A.N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J.J., Sandler, R.S., Keku, T.O., Fusobacterium is associated with colorectal adenomas. PLoS ONE, 8, 2013, e53653.
32. Mima, K., Sukawa, Y., Nishihara, R., Qian, Z.R., Yamauchi, M., Inamura, K., Kim, S.A., Masuda, A., Nowak, J.A., Nosho, K., et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1 (2015), 653–661.
33. Mongiello, J.R., Falkler, W.A. Jr., Sugar inhibition of oral Fusobacterium nucleatum haemagglutination and cell binding. Arch. Oral Biol. 24 (1979), 539–545.
34. Ozaki, M., Miyake, Y., Shirakawa, M., Takemoto, T., Okamoto, H., Suginaka, H., Binding specificity of Fusobacterium nucleatum to human erythrocytes, polymorphonuclear leukocytes, fibroblasts, and HeLa cells. J. Periodontal Res. 25 (1990), 129–134.
35. Richter, D.U., Jeschke, U., Makovitzky, J., Goletz, S., Karsten, U., Briese, V., Friese, K., Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta. Anticancer Res. 20:6D (2000), 5129–5133.
36. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/Î2-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206.
37. Sakuma, S., Yu, J.Y., Quang, T., Hiwatari, K., Kumagai, H., Kao, S., Holt, A., Erskind, J., McClure, R., Siuta, M., et al. Fluorescence-based endoscopic imaging of Thomsen-Friedenreich antigen to improve early detection of colorectal cancer. Int. J. Cancer 136 (2015), 1095–1103.
38. Schmalhofer, O., Brabletz, S., Brabletz, T., E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28 (2009), 151–166.
39. Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15 (2014), 317–328.
40. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 65 (2015), 5–29.
41. Springer, G.F., T and Tn, general carcinoma autoantigens. Science 224 (1984), 1198–1206.
42. Strauss, J., Kaplan, G.G., Beck, P.L., Rioux, K., Panaccione, R., Devinney, R., Lynch, T., Allen-Vercoe, E., Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17 (2011), 1971–1978.
43. Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.O., Sugai, T., An, B., et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74 (2014), 1311–1318.
44. Thomas, R.M., Jobin, C., The microbiome and cancer: is the “oncobiome” mirage real?. Trends Cancer 1 (2015), 24–35.
45. Tuttle, R.S., Strubel, N.A., Mourad, J., Mangan, D.F., A non-lectin-like mechanism by which Fusobacterium nucleatum 10953 adheres to and activates human lymphocytes. Oral Microbiol. Immunol. 7 (1992), 78–83.
46. Whitmore, S.E., Lamont, R.J., Oral bacteria and cancer. PLoS Pathog., 10, 2014, e1003933.
47. Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15 (2009), 1016–1022.
48. Yang, G.Y., Shamsuddin, A.M., Gal-GalNAc: a biomarker of colon carcinogenesis. Histol. Histopathol. 11 (1996), 801–806.
49. Yu, X., Harden, K., Gonzalez, L.C., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C.J., Clark, H., et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10 (2009), 48–57.